Sonoma Pharmaceuticals Announces Second Quarter FY 2019 Financial Results and Conference Call Nov 1, 2018
Sonoma Pharmaceuticals Announces Newly Published Results from Study of Hypochlorous Acid in Management of Hypertrophic and Keloid Scars Oct 25, 2018
Sonoma Pharmaceuticals Launches New Ceramax™ Skin Barrier Lotion with Skin-Enriching Lipogrid Technology™ Oct 17, 2018
Sonoma Pharmaceuticals Announces Licensing of Antimicrobial Hypochlorous Acid Solution for Management of Blepharitis in the Spanish/Portuguese Markets to Brill Pharma, S.L. Sep 26, 2018
Sonoma Pharmaceuticals Announces Results from Study of Sonoma’s Performance-Stabilized HOCl™ (Hypochlorous Acid) in Management of Acne Vulgaris Aug 28, 2018
Sonoma Pharmaceuticals Announces First Quarter FY 2019 Financial Results and Conference Call Jul 25, 2018
U.SK, dermatology arm of Brazilian NC Group, and Sonoma Pharmaceuticals Enter into License Agreement for Exclusive Rights to Sonoma’s Dermatology Products in Brazil Jun 5, 2018
